文献速递冠心病血脂与心血管预防

基于CT冠状动脉造影的FFR在稳定性胸痛评估与管理中的随机试验:FORECAST研究

Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.
PubMed 文献 · Eur Heart J · 2021-01-01

FORECAST随机试验纳入1400例稳定性胸痛患者,比较CTCA联合选择性FFRCT策略与标准临床路径。结果显示两组9个月总心脏费用无显著差异(实验组高£114,95%CI -£112至+£337,P=0.10),主要不良心脑血管事件相似(10.2% vs 10.6%),但实验组有创冠状动脉造影使用显著减少(19% vs 25%,P=0.01)。

要点

  • CTCA联合选择性FFRCT策略未显著改善费用或临床结局。
  • 该策略显著减少有创冠状动脉造影使用(19% vs 25%)。
  • 两组心绞痛状态与生活质量改善程度相似。

核心结论

  • 在稳定性胸痛患者中,CTCA联合选择性FFRCT策略与标准临床路径相比,费用和临床结局无显著差异。
  • 该策略显著减少了有创冠状动脉造影的使用。

研究设计与样本

  • 多中心随机对照试验,纳入1400例稳定性胸痛患者,随机分为实验组(CTCA联合选择性FFRCT)和标准临床路径组。
  • 主要终点为9个月总心脏费用,次要终点包括心绞痛状态、生活质量、主要不良心脑血管事件和有创冠状动脉造影使用。

主要发现

  • 实验组平均总心脏费用高£114(+8%),95%CI -£112(-8%)至+£337(+23%),差异无统计学意义(P=0.10)。
  • 主要不良心脑血管事件发生率实验组10.2%,标准组10.6%,差异无统计学意义。
  • 实验组有创冠状动脉造影使用率19%,标准组25%,差异有统计学意义(P=0.01)。
  • 两组心绞痛和生活质量在随访期间改善程度相似。

临床怎么用

  • 对于稳定性胸痛患者,可考虑采用CTCA联合选择性FFRCT策略以减少不必要的侵入性冠状动脉造影。
  • 该策略不增加总体心脏费用或不良事件风险。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Fractional flow reserve (FFRCT) using computed tomography coronary angiography (CTCA) determines both the presence of coronary artery disease and vessel-specific ischaemia. We tested whether an evaluation strategy based on FFRCT would improve economic and clinical outcomes compared with standard care. METHODS AND RESULTS: Overall, 1400 patients with stable chest pain in 11 centres were randomized to initial testing with CTCA with selective FFRCT (experimental group) or standard clinical care pathways (standard group). The primary endpoint was total cardiac costs at 9 months. Secondary endpoints were angina status, quality of life, major adverse cardiac and cerebrovascular events, and use of invasive coronary angiography. Randomized groups were similar at baseline. Most patients had an initial CTCA: 439 (63%) in the standard group vs. 674 (96%) in the experimental group, 254 of whom (38%) underwent FFRCT. Mean total cardiac costs were higher by £114 (+8%) in the experimental group, with a 95% confidence interval from -£112 (-8%) to +£337 (+23%), though the difference was not significant (P = 0.10). Major adverse cardiac and cerebrovascular events did not differ significantly (10.2% in the experimental group vs. 10.6% in the standard group) and angina and quality of life improved to a similar degree over follow-up in both randomized groups. Invasive angiography was reduced significantly in the experimental group (19% vs. 25%, P = 0.01). CONCLUSION: A strategy of CTCA with selective FFRCT in patients with stable angina did not differ significantly from standard clinical care pathways in cost or clinical outcomes, but did reduce the use of invasive coronary angiography.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Curzen N, Nicholas Z, Stuart B, et al. Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. Eur Heart J. 2021. PMID: 34269376. doi:10.1093/eurheartj/ehab444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。